quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:10:00·17d
PRRelease
Eledon Pharmaceuticals Inc. logo
Sana Biotechnology Inc. logo
Vericel Corporation logo

Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines

ELDN· Eledon Pharmaceuticals Inc.SANA· Sana Biotechnology Inc.VCEL· Vericel Corporation
Health Care
Original source

Companies

  • ELDN
    Eledon Pharmaceuticals Inc.
    Health Care
  • SANA
    Sana Biotechnology Inc.
    Health Care
  • VCEL
    Vericel Corporation
    Health Care

Recent analyst ratings

  • Sep 24SANAUpdateWedbush$5.00
  • Sep 17VCELUpdateBTIG Research-
  • Jul 3SANAUpdateMorgan Stanley$12.00
  • Jun 18ELDNUpdateH.C. Wainwright$9.00
  • Mar 18SANAUpdateCitizens JMP$5.00
  • Mar 14SANAUpdateJefferies$7.00

Related

  • PR21h
    Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
  • PR3d
    NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
  • SEC10d
    SEC Form 424B5 filed by Sana Biotechnology Inc.
  • SEC10d
    Sana Biotechnology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR10d
    Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
  • INSIDER15d
    SEC Form 4 filed by Bishop Hans Edgar
  • INSIDER17d
    SEC Form 4 filed by Hopper Jonathan Mark
  • PR21d
    MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022